Marketing-authorisation holder
BLES Biochemicals
3 medicines in 2 countries, as authorisation holder and manufacturer.
Medicines
Every medicine in the registers under its name, current ones first.
3 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BLES27 mg / ml + 500 mcg / ml · Suspension | Phospholipid, Surfactant-associated proteins sp-b and sp-c | Canada | Marketed | 2002 |
| BLES suspension | Surfactant-associated proteins b and c, Phospholipids | Saudi Arabia | Authorised | |
| BLES suspension | Surfactant-associated proteins b and c, Phospholipids | Saudi Arabia | Authorised |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Saudi Arabia | 2 | 2 | 0 | CompaniesAll medicines |
| Canada | 1 | 1 | 0 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- Other respiratory system productsRespiratory system · ATC R07A
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- bles biochemicals inc
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 3
- Countries
- 2
- Roles
- Authorisation holder and manufacturer



